In this study, we aimed to perform in-depth evaluations of three second-generation tau PET tracers (PI2620, MK6240 and RO948) in AD, CBD and PSP brain tissue using in vitro imaging and immunohistochemistry techniques. The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.